Pharma Globenewswire

Global Digital Biomarkers Market Expected to Witness Strong Growth with a CAGR of ~17% by 2032 | DelveInsight

20 November 2025

The demand for digital biomarkers is rising rapidly, driven primarily by the global increase in chronic diseases, including cardiovascular, neurological, and metabolic disorders. This growth is further supported by the expanding elderly population, which is more vulnerable to age-related health conditions. Additionally,

Uncategorised

Cataract Surgery Complications Market Outlook to 2034: Key Trends, Growth Drivers, and Forecast Analysis | DelveInsight

20 November 2025

The cataract surgery complications market is projected to grow steadily from 2025 to 2034, driven by the introduction of new treatments, advancements in diagnostic technologies, increased awareness of the condition, and a growing number of reported cases, creating a dynamic and promising

Uncategorised

Mydriasis Market to Reach New Heights in Growth by 2034 | DelveInsight Predicts

19 November 2025

DelveInsight’s “Mydriasis Market Insights, Epidemiology, and Market Forecast-2034” report delivers a comprehensive analysis of the Mydriasis market, covering historical and projected epidemiology, market trends, and developments across the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom, and Japan. This report

Uncategorised

Global Cataract Surgery Devices Market to Grow at a CAGR of 5.07% by 2032 | DelveInsight

19 November 2025

According to DelveInsight’s analysis, the growth of the Cataract Surgery Devices Market is primarily driven by the rising prevalence of cataracts and vision impairment, increased incidence of lifestyle-related conditions contributing to cataract development, the expanding geriatric population, and accelerated product development initiatives

Uncategorised

Marginal Zone Lymphoma Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape | DelveInsight

19 November 2025

Marginal Zone Lymphoma Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Beigene, InnoCare Pharma, Hutchmed, Incyte, Innovent, MorphoSys, Beijing Mabworks Biotech (Las Vegas, Nevada, United States) As per DelveInsight’s evaluation, globally, the Marginal Zone Lymphoma (MZL)

Uncategorised

Clostridium Difficile Infections Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies | DelveInsight

19 November 2025

As per DelveInsight’s latest evaluation, the global Clostridium Difficile Infections therapeutic pipeline includes 20+ active companies involved in advancing 22+ CDI treatment candidates, covering clinical trials, therapeutic approaches, mechanisms of action, routes of administration, and key ongoing developments. The “Clostridium Difficile Infections

Market Insights

EGFR Inhibitor Market Expected to Gain Momentum Through 2034 | DelveInsight

19 November 2025

DelveInsight’s “EGFR Inhibitor Market Insights, Epidemiology, and Market Forecast-2034” report provides an in-depth analysis of the EGFR Inhibitor market, including historical and projected epidemiology trends, as well as market dynamics across the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom,

Market Insights

Myelofibrosis Market Poised to Expand Significantly at 9% CAGR from 2025 to 2034 | DelveInsight

19 November 2025

The introduction of novel therapies, including BESREMi (PharmaEssentia/AOP Orphan Pharmaceuticals), INCB057643 (Incyte), XPOVIO (Karyopharm Therapeutics), RYTELO (Geron), REBLOZYL (Bristol Myers Squibb), Navtemadlin (Kartos Therapeutics), Pelabresib (Novartis), among others, is poised to reshape the myelofibrosis treatment landscape. DelveInsight’s Myelofibrosis Market Insights report includes

Market Insights

KRAS Inhibitors Market Set for Breakneck 35% CAGR Growth by 2034 | DelveInsight

19 November 2025

The KRAS inhibitors market is projected to witness strong expansion, fueled by the growing burden of cancer, wider access to advanced therapies, and a promising pipeline featuring candidates such as Olomorasib (Eli Lilly), MK-1084 (Merck/Taiho/Astex Pharmaceuticals), Divarasib (Roche), Daraxonrasib (Revolution Medicines), Onvansertib

Latest

Global Digital Biomarkers Market Expected to Witness Strong Growth with a CAGR of ~17% by 2032 | DelveInsight

Cataract Surgery Complications Market Outlook to 2034: Key Trends, Growth Drivers, and Forecast Analysis | DelveInsight

Mydriasis Market to Reach New Heights in Growth by 2034 | DelveInsight Predicts

Global Cataract Surgery Devices Market to Grow at a CAGR of 5.07% by 2032 | DelveInsight

Marginal Zone Lymphoma Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape | DelveInsight

Clostridium Difficile Infections Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies | DelveInsight

EGFR Inhibitor Market Expected to Gain Momentum Through 2034 | DelveInsight

Myelofibrosis Market Poised to Expand Significantly at 9% CAGR from 2025 to 2034 | DelveInsight

KRAS Inhibitors Market Set for Breakneck 35% CAGR Growth by 2034 | DelveInsight

Recent Posts

Banner

Newsletter

Authors